Bill > HCR3

This concurrent resolution recognizes and honors Dr. Brian Druker, a pioneering medical researcher from Oregon who made groundbreaking contributions to cancer treatment. The resolution highlights Dr. Druker's significant achievements, including developing Gleevec, a revolutionary cancer drug approved by the FDA in 2001 that targets only cancer cells and has saved hundreds of thousands of lives worldwide. It traces his professional journey from graduating with medical degrees from the University of California, San Diego, to becoming the director of the OHSU Knight Cancer Institute in 2007, where he has led innovative cancer research. The resolution emphasizes his numerous professional accomplishments, including receiving prestigious awards like the Lasker-DeBakey Award in 2009 and the Sjöberg Prize in 2019, leading a successful $1 billion fundraising effort for cancer research, and establishing the Cancer Early Detection Advanced Research Center. Ultimately, the resolution celebrates Dr. Druker as Oregon's most renowned scientist and a world-class leader in the fight against cancer, recognizing his exceptional leadership and service to both the state of Oregon and the global medical community.

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HCR3